Biomarker research in Parkinson's disease : objective measures needed for patient stratification in future cause-directed trials
Imaging dopamine transporters in Parkinson's disease
Olfaction as a biomarker in Parkinson's disease
Problems associated with fluid biomarkers for Parkinson's disease
Quantification of α-synuclein in cerebrospinal fluid as a biomarker candidate : review of the literature and considerations for future studies
Urate : a novel biomarker of Parkinson's disease risk, diagnosis and prognosis
Autosomal recessive mutations in the development of Parkinson's disease
Biomarkers in Parkinson's disease : a funder's perspective
Biomarkers in Parkinson's disease : a venture capitalist's perspective
Identification of novel genetic markers and improved treatment options for diabetic kidney disease
Apoptosis in nonalcoholic steatohepatitis with normal aminotransferase values : zooming in on cytokeratin 18 fragments
Launch of new cystic fibrosis test announced by industry leader
TB signature may help researchers develop tools to predict development of active disease
Microfluidics-based test for analyzing molecular basis of brain cancer
RNA biomarker assay kit for translational medical researchers
Genome-scale sequencing guides treatment in rare cancer type
Three-biomarker ‘signature’ may help to classify Alzheimer's disease patients
Vascular dysfunction biomarkers are elevated in children with HIV
Circulating proteins predict liver fibrosis in hepatitis C infection
Unique tumor-associated molecule supports the growth and progression of oral carcinoma
High clusterin levels predate evidence of Alzheimer's disease
Cytokine patterns after therapy with Avonex®, Rebif®, Betaferon® and CinnoVexTM in relapsing–remitting multiple sclerosis in Iranian patients
miRNAs as biomarkers for management of patients with colorectal cancer
The need for noninvasive biomarkers for drug safety in neonatal circulation